Skip to main content
See every side of every news story
Published loading...Updated

iOncologi, Inc. Announces the Appointment of Dr. Mona Flores and Mr. Paolo Fundarò to Its Board of Directors

Summary by The AI Journal
GAINESVILLE, Fla., March 17, 2025 /PRNewswire/ — iOncologi, Inc. (www.ioncologi.com), a clinical-stage biopharmaceutical company pioneering novel immunotherapies for cancer treatment, today announced the appointment of Dr. Mona Flores and Mr. Paolo Fundarò to its Board of Directors. Their combined expertise in AI-driven healthcare innovation, biopharmaceutical leadership, and strategic biotech investment will strengthen iOncologi’s mission to ra…

2 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The AI Journal broke the news on Monday, March 17, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal